Regulation of biosimilar medicines and current perspectives on interchangeability and policy
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-018-2542-1
Abstract: Competition arising from the increasing availability of biosimilar medicines has resulted in healthcare savings and has provided greater patient access to high cost therapeutics in Europe. The biosimilar market in the USA is relatively new… read more here.
Keywords: policy; regulation biosimilar; interchangeability; medicines current ... See more keywords